Misplaced Pages

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 23:20, 14 November 2011 (Updating {{chembox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'CASNo_Ref') per Chem/Drugbox validation (repor...). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dazoxiben

Identifiers
CAS Number	78218-09-4
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL267473
ChemSpider	47885
PubChem CID	53001
CompTox Dashboard (EPA)	DTXSID9045639
InChI InChI=1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)Key: XQGZSYKGWHUSDH-UHFFFAOYSA-N InChI=1/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)Key: XQGZSYKGWHUSDH-UHFFFAOYAY
SMILES O=C(O)c2ccc(OCCn1ccnc1)cc2
Properties
Chemical formula	C12H12N2O3
Molar mass	232.2 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is  ?) Infobox references

Dazoxiben is an orally active thromboxane synthase inhibitor. It has shown a significant clinical improvement in patients with Raynaud's syndrome.

References

1. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with |pmid=6337601 instead.
2. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with |pmid=6337601 instead.

• Drugs